Cargando…
Plasma Membrane Proteomics of Human Breast Cancer Cell Lines Identifies Potential Targets for Breast Cancer Diagnosis and Treatment
The use of broad spectrum chemotherapeutic agents to treat breast cancer results in substantial and debilitating side effects, necessitating the development of targeted therapies to limit tumor proliferation and prevent metastasis. In recent years, the list of approved targeted therapies has expande...
Autores principales: | Ziegler, Yvonne S., Moresco, James J., Tu, Patricia G., Yates, John R., Nardulli, Ann M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100819/ https://www.ncbi.nlm.nih.gov/pubmed/25029196 http://dx.doi.org/10.1371/journal.pone.0102341 |
Ejemplares similares
-
Proteomic analysis identifies highly expressed plasma membrane proteins for detection and therapeutic targeting of specific breast cancer subtypes
por: Ziegler, Yvonne S., et al.
Publicado: (2018) -
Integration of Breast Cancer Secretomes with Clinical Data Elucidates Potential Serum Markers for Disease Detection, Diagnosis, and Prognosis
por: Ziegler, Yvonne S., et al.
Publicado: (2016) -
Proteomic Dynamics of Breast Cancer Cell Lines Identifies Potential Therapeutic Protein Targets
por: Sun, Rui, et al.
Publicado: (2023) -
A five‐miRNA panel in plasma was identified for breast cancer diagnosis
por: Li, Minghui, et al.
Publicado: (2019) -
Combining phenotypic and proteomic approaches to identify membrane targets in a ‘triple negative’ breast cancer cell type
por: Rust, Steven, et al.
Publicado: (2013)